Related Experiment Video
Updated: Dec 24, 2025
06:40
In Vivo Imaging of Reactive Oxygen Species in a Murine Wound Model
Published on: November 17, 2018
11.6K
Intravenous Laser Wavelength Irradiation Effect on Interleukins: IL-1α, IL-1β, IL6 in Diabetic Rats
A Amjadi1, H Mirmiranpor2, S Khandani3
1(Corresponding Author) Laser and Medical Physics Lab, Department of Physics, Sharif University of Technology, Tehran, Iran, E-mail: amjadi@sharif.edu, Tel: +98-2166164521 Fax:+98-2166022711.
Laser Therapy
|April 8, 2020
Summary
Low-Level Laser Therapy (LLLT) using shorter wavelengths, such as blue light (450 nm), more effectively reduces inflammation markers like interleukins in diabetic rats compared to longer wavelengths. This finding highlights wavelength-specific effects in LLLT for managing diabetes-related inflammation.
Area of Science:
- Biomedical Engineering
- Photomedicine
- Endocrinology
Background:
- Diabetes mellitus is associated with chronic inflammation.
- Interleukins (IL-1α, IL-1β, IL-6) are key inflammatory mediators.
- Low-Level Laser Therapy (LLLT) is explored for therapeutic benefits.
Purpose of the Study:
- To investigate the effect of different laser wavelengths on interleukin levels in diabetic rats.
- To compare the efficacy of various laser wavelengths in reducing inflammation.
Main Methods:
- Diabetes was induced in Wistar rats using streptozotocin.
- Rats received intravenous laser therapy with IR (808 nm), Red (638 nm), Green (532 nm), and Blue (450 nm) lasers.
- Inflammatory parameters (interleukins) were measured at 2, 6, and 24 hours post-therapy.
Main Results:
- All tested laser wavelengths reduced inflammatory parameters compared to controls.
- Shorter laser wavelengths demonstrated a more significant reduction in interleukins.
- Blue light (450 nm) showed the highest efficacy in lowering inflammatory markers.
Conclusions:
- Intravenous LLLT with shorter wavelengths is more effective in managing inflammation in diabetic rats.
- Blue light (450 nm) is superior to red (638 nm) and IR (808 nm) lasers for reducing interleukin levels.
- LLLT wavelength selection is crucial for optimizing therapeutic outcomes in diabetic conditions.
